Diffusion-weighted imaging versus contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomas
- 19 June 2017
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 27 (12) , 4913-4922
Abstract
To compare the performance of diffusion-weighted imaging (DWI) with that of contrast-enhanced MRI in differentiating renal oncocytomas from chromophobe renal cell carcinomas (RCCs).Keywords
This publication has 35 references indexed in Scilit:
- Current Role of Renal Biopsy in Urologic PracticeUrologic Clinics of North America, 2017
- Use of DWI in the Differentiation of Renal Cortical TumorsAmerican Journal of Roentgenology, 2016
- EAU Guidelines on Renal Cell Carcinoma: 2014 UpdateEuropean Urology, 2015
- Diagnostic Significance of Diffusion-Weighted MRI in Renal CancerBioMed Research International, 2015
- Imaging spectrum of renal oncocytomas: a pictorial review with pathologic correlationInsights into Imaging, 2014
- Diagnostic accuracy of segmental enhancement inversion for the diagnosis of renal oncocytoma using biphasic computed tomography (CT) and multiphase contrast-enhanced magnetic resonance imaging (MRI)European Radiology, 2014
- Utility and limitations of 3-Tesla diffusion-weighted magnetic resonance imaging for differentiation of renal tumorsEuropean Journal of Radiology, 2014
- Metastatic renal oncocytomaJournal of Clinical Pathology, 2007
- Diffusion-Weighted MRI in the Body: Applications and Challenges in OncologyAmerican Journal of Roentgenology, 2007
- Diagnostic value of CT-guided biopsy of indeterminate renal massesClinical Radiology, 2004